Revolutionizing Melanoma Care: SkylineDx’s CP-GEP Test Minimizes Surgical Risks
SkylineDx, a leading diagnostics innovator specializing in molecular diagnostics for oncology, inflammatory, and infectious diseases, has announced significant findings from a Danish validation study recently published in the Journal of Surgical Oncology. This study confirms that SkylineDx’s Merlin Assay, also…